96 related articles for article (PubMed ID: 11210857)
1. Immunocytochemical detection of MMP-3 and -10 expression in hepatocellular carcinomas.
Bodey B; Bodey B; Siegel SE; Kaiser HE
Anticancer Res; 2000; 20(6B):4585-90. PubMed ID: 11210857
[TBL] [Abstract][Full Text] [Related]
2. Immunocytochemical detection of matrix metalloproteinase expression in prostate cancer.
Bodey B; Bodey B; Siegel SE; Kaiser HE
In Vivo; 2001; 15(1):65-70. PubMed ID: 11286132
[TBL] [Abstract][Full Text] [Related]
3. Matrix metalloproteinase expression in malignant melanomas: tumor-extracellular matrix interactions in invasion and metastasis.
Bodey B; Bodey B; Siegel SE; Kaiser HE
In Vivo; 2001; 15(1):57-64. PubMed ID: 11286131
[TBL] [Abstract][Full Text] [Related]
4. Invasion and metastasis: the expression and significance of matrix metalloproteinases in carcinomas of the lung.
Bodey B; Bodey B; Gröger AM; Siegel SE; Kaiser HE
In Vivo; 2001; 15(2):175-80. PubMed ID: 11317524
[TBL] [Abstract][Full Text] [Related]
5. Immunocytochemical detection of the expression of members of the matrix metalloproteinase family in adenocarcinomas of the pancreas.
Bodey B; Bodey B; Siegel SE; Kaiser HE
In Vivo; 2001; 15(1):71-6. PubMed ID: 11286133
[TBL] [Abstract][Full Text] [Related]
6. Matrix metalloproteinases in neoplasm-induced extracellular matrix remodeling in breast carcinomas.
Bodey B; Bodey B; Siegel SE; Kaiser HE
Anticancer Res; 2001; 21(3B):2021-8. PubMed ID: 11497292
[TBL] [Abstract][Full Text] [Related]
7. Matrix metalloproteinase expression in childhood astrocytomas.
Bodey B; Bodey B; Siegel SE; Kaiser HE
Anticancer Res; 2000; 20(5A):3287-92. PubMed ID: 11062755
[TBL] [Abstract][Full Text] [Related]
8. Significant differences in the matrix metalloproteinase expression profiles of spontaneous medulloblastomas/primitive neuroectodermal tumors as compared with their xenografted, established tumor cell line derived counterparts.
Bodey B; Bodey B; Siegel SE; Kaiser HE
In Vivo; 2000; 14(5):675-82. PubMed ID: 11212845
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of matrix metalloproteinase expression in colorectal carcinomas.
Bodey B; Bodey B; Siegel SE; Kaiser HE
In Vivo; 2000; 14(5):659-66. PubMed ID: 11212843
[TBL] [Abstract][Full Text] [Related]
10. Matrix metalloproteinase expression in childhood medulloblastomas/primitive neuroectodermal tumors.
Bodey B; Bodey B; Siegel SE; Kaiser HE
In Vivo; 2000; 14(5):667-73. PubMed ID: 11212844
[TBL] [Abstract][Full Text] [Related]
11. Differential expression of matrilysin-1 (MMP-7), 92 kD gelatinase (MMP-9), and metalloelastase (MMP-12) in oral verrucous and squamous cell cancer.
Impola U; Uitto VJ; Hietanen J; Hakkinen L; Zhang L; Larjava H; Isaka K; Saarialho-Kere U
J Pathol; 2004 Jan; 202(1):14-22. PubMed ID: 14694517
[TBL] [Abstract][Full Text] [Related]
12. Expression of matrix metalloproiteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) in hepatocellular carcinoma tissue, compared with the surrounding non-tumor tissue.
Matsunaga Y; Koda M; Murawaki Y
Res Commun Mol Pathol Pharmacol; 2004; 115-116():143-50. PubMed ID: 17564313
[TBL] [Abstract][Full Text] [Related]
13. [Expression of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in the hepatocellular carcinomas].
Wei QY; Wu YQ; Fan SQ
Hunan Yi Ke Da Xue Xue Bao; 2003 Jun; 28(3):212-6. PubMed ID: 14653069
[TBL] [Abstract][Full Text] [Related]
14. Dynamic expression of matrix metalloproteinases (MMP-2, -9 and -14) and the tissue inhibitors of MMPs (TIMP-1, -2 and -3) at the implantation site during tubal pregnancy.
Bai SX; Wang YL; Qin L; Xiao ZJ; Herva R; Piao YS
Reproduction; 2005 Jan; 129(1):103-13. PubMed ID: 15615902
[TBL] [Abstract][Full Text] [Related]
15. Difference in gene expression for matrix metalloproteinase-1 between early and advanced hepatocellular carcinomas.
Okazaki I; Wada N; Nakano M; Saito A; Takasaki K; Doi M; Kameyama K; Otani Y; Kubochi K; Niioka M; Watanabe T; Maruyama K
Hepatology; 1997 Mar; 25(3):580-4. PubMed ID: 9049202
[TBL] [Abstract][Full Text] [Related]
16. [Expression of matrix metalloproteinase-2, 9 and their inhibitor-TIMP 1,2 in human squamous cell carcinoma of uterine cervix].
Zhou CY; Yao JF; Chen XD
Ai Zheng; 2002 Jul; 21(7):735-9. PubMed ID: 12479097
[TBL] [Abstract][Full Text] [Related]
17. Matrix-metalloproteinases in Hodgkin lymphoma.
Thorns C; Bernd HW; Hatton D; Merz H; Feller AC; Lange K
Anticancer Res; 2003; 23(2B):1555-8. PubMed ID: 12820423
[TBL] [Abstract][Full Text] [Related]
18. Matrilysin-1 (MMP-7) and MMP-19 are expressed by Paget's cells in extramammary Paget's disease.
Kuivanen T; Tanskanen M; Jahkola T; Impola U; Asko-Seljavaara S; Saarialho-Kere U
J Cutan Pathol; 2004 Aug; 31(7):483-91. PubMed ID: 15239678
[TBL] [Abstract][Full Text] [Related]
19. Expression of matrix metalloproteinase (MMP)-7 and MMP-13 and loss of MMP-19 and p16 are associated with malignant progression in chronic wounds.
Impola U; Jeskanen L; Ravanti L; Syrjänen S; Baldursson B; Kähäri VM; Saarialho-Kere U
Br J Dermatol; 2005 Apr; 152(4):720-6. PubMed ID: 15840104
[TBL] [Abstract][Full Text] [Related]
20. Increased extracellular matrix remodeling is associated with tumor progression in human hepatocellular carcinomas.
Théret N; Musso O; Turlin B; Lotrian D; Bioulac-Sage P; Campion JP; Boudjéma K; Clément B
Hepatology; 2001 Jul; 34(1):82-8. PubMed ID: 11431737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
